Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
121 participants
INTERVENTIONAL
2004-02-29
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
STARR
STARR
Stapled Trans-Anal Rectal Resection for the treatment of ODS
2
Biofeedback
Biofeedback
electromyographic-based treatment sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
STARR
Stapled Trans-Anal Rectal Resection for the treatment of ODS
Biofeedback
electromyographic-based treatment sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to comprehend, follow, and provide written informed consent.
3. Minimum ODS Score of seven at screening.
4. Negative pregnancy test, by urine.
5. 'Obstructed' defecation requiring straining/digitation as presenting lead symptom.
6. Adequate external sphincter on rectal digital examination.
7. Evidence of anterior rectocele and/or rectal intussusception on dynamic defecography. (Note: dynamic defecography taken within 12 months will be acceptable)
8. Willingness to comply with study requirements including follow-up visits
Exclusion Criteria
1. Enterocele at rest- requiring surgery.
2. Faecal incontinence (soiling and faecal urgency is admissible).
3. Any anterior defect, colpocele or cystocele requiring a combined surgical approach.
4. Physical or psychological condition which would impair participation in the study.
5. Participation in any other device or drug study within 90 days prior to enrollment.
6. Planned participation in any other device study during the timeframe of this study.
7. General contraindication for surgery.
8. Previous transanal surgery for ODS.
9. Immunocompromised subjects
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aysgarth Statistics
UNKNOWN
Physicians World GmbH
UNKNOWN
Ethicon Endo-Surgery (Europe) GmbH
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul A Lehur, MD
Role: PRINCIPAL_INVESTIGATOR
Institut des Maladies de l'Appareil Digestif (IMAD), University Hospital of Nantes, 1 place A Ricordeau, F-44093 Nantes Cedex 01
Goran Ribaric, MD, PhD
Role: STUDY_DIRECTOR
Ethicon Endo-Surgery (Europe) GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chirurgie Proctologique
Besançon, , France
Clinique des Cèdres
Cornebarrieu, , France
Groupe Hospitalier Diaconesses Croix Saint-Simon
Paris, , France
Hopital Bagatelle
Talence, , France
CHU Purpan
Toulouse, , France
Ospedale S. Giuseppe
Milan, , Italy
Ospedale "Franchini" di Montecchio Emilia
Montecchio Emilia, , Italy
Ospedale Santa Maria degli Angeli
Pordenone, , Italy
Royal Liverpool University Hospital
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ODS-HJH-4
Identifier Type: -
Identifier Source: org_study_id